story of the week
Two Fingolimod Doses vs Glatiramer Acetate for Relapsing-Remitting MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial
JAMA Neurol 2021 Jan 01;78(1)1-13, BAC Cree, MD Goldman, JR Corboy, BA Singer, EJ Fox, DL Arnold, C Ford, B Weinstock-Guttman, A Bar-Or, S Mientus, D Sienkiewicz, Y Zhang, R Karan, N TenenbaumFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.